BlackBerry Ltd. said it was unaware of any material, undisclosed corporate developments that caused a 17.7 percent surge in its share price at $16.53 on Monday, even after it settled a patent royalties dispute with Facebook Inc. on Jan 15.
The Canadian security software supplier made the statement in response to a request from securities regulator the Investment Industry Regulatory Organization of Canada.
Consequently, the share price increase lifted gains to over 150 percent since the start of January.
It was the seventh consecutive session of gains for the Canadian security software supplier.
Several Blackberry senior executives sold shares in the company last week, with Chief Marketing Officer Mark Wilson selling 78,500 shares and Chief Financial Officer Steve Rai offloading 32,954 shares.


Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 



